At the Medical University of South Carolina, researchers have made an important discovery that could change the way patients ...

Medically reviewed by Beth Thomas, PharmD Fact checked by Nick Blackmer N-acetylcysteine (NAC) supplements are proposed to ...

The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions.

Heart attacks have remained the leading cause of death in the United States for over a century. Most treatments focus on ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

On Monday, the FDA approved Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) supplemental New Drug Application (sNDA) for its ...

Shares of Cumberland Pharmaceuticals (CPIX) doubled on Tuesday morning, reaching levels not seen since March 2023, following ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a ...

L-methylfolate calcium (Metafolin) 6mg, Algae-S powder 90.314mg, methylcobalamin 2mg, N-acetylcysteine 600mg; caplets. Avoid if renal stones occur. Do not administer to critically ill patients ...

The major findings of this study of exacerbations of COPD can be summarised as follows: (a) among patients with elevated CRP, those receiving NAC were more likely to have this marker normalised ...